|
1 Castaman G. Desmopressin for the treatment of haemophilia [J]. Haemophilia, 2008, 14(Suppl 1): 15-20.
|
|
2 Castaman G, Mancuso ME, Giacomelli SH, et al. Molecular and phenotypic determinants of response to desmopressin in adult patients with mild hemophilia A[J]. J Thromb Hemost, 2009,7:1824-1831.
|
|
3 Kaufmann JE, Oksche A, Wollllheim CB, et al. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP[J]. J Clin Invest, 2000, 106:107-116.
|
|
4 Federici AB. The use of desmopressin in von Willebrand disease:The experience of the first 30 years(1977-2007)[J]. Haemophilia, 2008, 14(Suppl 1):5-14.
|
|
5 Franchini M, Zaffanello M, Lippi G. The use of desmopressin in mild hemophilia A[J]. Blood Coagul Fibrinolysis, 2010, 21(7):615-619.
|
|
6 Lethagen S, Harris AS, Nilsson IM. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I[J]. Blut, 1990, 60: 187-191.
|
|
7 Rodeghiero F, Castaman G, DiBona E, et al. Consistency of responses to repeated DDAVP infusions in patients with von Willebrand' s disease and hemophilia A [ J]. Blood, 1989, 74: 1997-2000.
|
|
8 Mannucci PM, Bettega D, Cattaneo M. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP) [J]. Br J Haematol, 1992, 82: 87-93.
|
|
9 Ozgonenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin [J]? Postgrad Med J, 2007, 83(977):159-163.
|
|
10 Franchini M, Mannucci PM. Co-morbidities and quality of life in elderly persons with hemophilia [J]. Br J Hematol, 2010, 148:522-533.
|
|
11 Franchini M, Favaloro EJ, Lippi G. Mild hemophilia A [ J]. J Thromb Hemost, 2010, 8(3): 421-432.
|
|
12 Franchini M, Zaffanello M, Lippi G. The use of desmopressin in mild hemophilia A[J]. Blood Coagul Fibrinolysis, 2010, 21(7):615-619.
|
|
13 Lethagen S. Desmopressin in mild hemophilia A: Indications, limitations, efficacy, and safety [J]. Semin Thromb Hemost, 2003, 29: 101-106.
|
|
14 Castaman G, Mancuso ME, Giacomelli SH, et al. Molecular and phenotypic determinants of response to desmopressin in adult patients with mild hemophilia A[J]. J Thromb Haemost, 2009, 7: 1824-1831.
|
|
15 Riccardi F, Rivolta GF, Franchini M, et al. Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy[J]. J Thromb Haemost, 2009, 7: 1234-1235.
|
|
16 De la Fuente B, Kasper CK, Rickles FR, et al. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin [J]. Ann Intern Med, 1985, 103: 6-14.
|
|
17 Leissinger C, Becton D, Cornell C, et al. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A[J]. Haemophilia, 2001, 7: 258-266.
|
|
18 Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy in factor Ⅷ-deficient women [J]. Blood, 2005, 105:3382.
|
|
19 Nolan B, White B, Smith J, O'Reilly C, et al. Desmopressin: Therapeutic limitations in children and adults with inherited coagulation disorders[J]. Br J Haematol, 2000, 109: 865-869.
|
|
20 Revel-Vilk S, Blanchette V, Sparling C, et al. DDAVP challenge tests in boys with mild/moderate haemophilia A [J]. Br J Haematol, 2002, 117: 947-951.
|
|
21 Sharathkumar A, Lillicrap D, Blanchette VS, et al. Intensive exposure to factor Ⅷ is a risk factor for inhibitor development in mild hemophilia A[J]. J Thromb Haemost, 2003, 1: 1228-1236.
|
|
22 Shima M. Diagnosis and treatment of acquired hemophilia [J]. Rinsho Ketsueki, 2010, 51: 1531-1538.
|
|
23 Ehl S, Severin T, Sutor HS. DDAVP (desmopressin; 1-deaminocys-8-d-arginine-vasopressin) treatment in children with haemophilia B[J]. Br J Haematol, 2000, 111: 1260-1262.
|
|
24 Federici AB. The use of desmopressin in von Willebrand disease:The experience of the first 30 years(1977-2007)[J]. Haemophilia, 2008, 14(Suppl 1): 5-14.
|
|
25 Castaman G, Lethagen S, Federici AB, et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (vWD): Results from the European Study MCMDM-1 vWD[J]. Blood, 2008, 111(7): 3531-3539.
|
|
26 Castaman G, Eikenboom JCJ, Rodeghiero F, et al. A novel candidate mutation (Arg 611→His) in type 1 "platelet discordant" von Willebrand's disease with desmopressin-induced thrombocytopenia [J]. Br J Haematol, 1995, 89: 656-659.
|
|
27 Federici AB, Rand JH, Bucciarelli P, et al. Acquired von Willebrand syndrome: Data from an international registry [J]. Thromb Haemost, 2000, 84: 345-349.
|